- Author:
Katsuro ICHIMASA
1
;
Shin-ei KUDO
;
Ker-Kan TAN
;
Jonathan Wei Jie LEE
;
Khay Guan YEOH
Author Information
- Publication Type:Perspective
- From:Gut and Liver 2024;18(2):218-221
- CountryRepublic of Korea
- Language:EN
- Abstract: The current standard treatment for muscularis propria-invasive (T2) colorectal cancer is surgical colectomy with lymph node dissection. With the advent of new endoscopic resection techniques, such as endoscopic full-thickness resection or endoscopic intermuscular dissection, T2 colorectal cancer, with metastasis to 20%-25% of the dissected lymph nodes, may be the next candidate for endoscopic resection following submucosal-invasive (T1) colorectal cancer. We present a novel endoscopic treatment strategy for T2 colorectal cancer and suggest further study to establish evidence on oncologic and endoscopic technical safety for its clinical implementation.